NEW YORK (GenomeWeb) – Guardant Health has raised $50 million in a Series C financing round, the company said today.

The financing, which was led by Lightspeed Venture Partners, with Formation 8 and existing investors Khosla Ventures and Sequoia Capital participating, brings the company's total funding to date to just under $100 million. The company raised $30 million in a Series B round last April.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more